Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
OncologyBreast Cancer: The Role of Lifestyle in Reducing Risk
By Carolina Lima | Published October 6th, 2025 | 3 min read#BreastCancerAwareness #PinkOctober #OncologyUpdatesBreast cancer is the most frequently diagnosed cancer among women worldwide and its prevention remains a global health priority. While genetic predisposition—particularly BRCA1 and BRCA2 mutations— often dominates public discourse, recent evidence suggests that lifestyle factors significa
OncologyBreast cancer: could the key lie in our diet and our bacteria?
By Lila Rouland | Published October 4th, 2025 | 2 min read#Oncology #BreastCancer #Microbiome #Nutrition #Chemotherapy Breast cancer (BC) remains the most common cancer among women worldwide and one of the leading causes of mortality. Its rising incidence is linked not only to genetic and hormonal factors, but also to modifiable lifestyle elements such as diet, obesity, and sedentary behavior. Thi
OncologyTransforming lifestyle habits during chemotherapy: Insights from the LEANer trial
By Lila Rouland | Published October 3rd, 2025 | 2 min read#BreastCancer #Exercise #ChemotherapyThe Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) trial evaluated whether a structured lifestyle intervention could improve physical activity (PA) and dietary quality in women undergoing chemotherapy for breast cancer. While most studies focus on the post-treatment period, this trial
OncologyCan we really predict relapse after breast surgery?
By Ana Espino | Published on october 3rd, 2025 | 3 min read#PinkOctober #BreastCancer #IBTR #Recurrence Ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery for invasive breast cancer remains a major concern in clinical practice, both from oncological and psychological standpoints. Although therapeutic advances have helped reduce this risk, it still persists for some patients
OncologyCDK4/6: The double-edged sword?
By Ana Espino | Published on october 2nd, 2025 | 3 min read #Oncology #PinkOctober #CDK4/6 #QualityOfLife CDK4/6 inhibitors have revolutionized the treatment of advanced or metastatic HR+/HER2- breast cancer when combined with hormone therapy. These treatments significantly prolong progression-free survival, while being oral and generally well tolerated. However, this therapeutic advancement comes
OncologyLess weight, less edema?
By Ana Espino | Published on october 1st, 2025 | 3 min read#PinkOctober #BCRL #Lymphedema #Cancer Lymphedema secondary to breast cancer (BCRL) affects approximately 20% of women treated for breast cancer. It is a chronic swelling of the upper limb caused by impaired lymphatic drainage, often resulting from axillary surgery or radiotherapy. This condition is disabling, painful, and significantly im
Gastroenterology and HepatologyGallstones: Genetics strikes back!
By Ana Espino | Published on september 30, 2025 | 3 min read#GallstoneDisease #GeneticLoci #GeneticVariants Gallstone disease, or cholelithiasis, is an extremely common digestive condition, affecting up to 25% of adults in some populations. Although often asymptomatic, it can lead to serious complications such as acute cholecystitis, biliary pancreatitis, or chronic debilitating pain. While metabo
Public Health and Social MedicinePregnancy at risk: do heat and pollution tip the balance?
By Ana Espino | Published on september 29, 2025 | 3 min read#PretermBirth #AirPollution #Pregnancy #Birth Preterm birth (PTB) is one of the leading causes of neonatal morbidity and mortality, especially in low- and middle-income countries (LMICs). Many environmental risk factors are poorly monitored in these settings, particularly exposure to excessive heat and air pollution. PM2.5 and black carbo
GynecologyMale contraception: towards a silent revolution?
By Ana Espino | Published on september 26, 2025 | 3 min read#Contraception #MaleContraception #Gynecology Contraception remains a major issue in reproductive health, still largely shouldered by women. On the male side, the options are few and outdated: condoms, withdrawal, or vasectomy, each with obvious limitations in terms of effectiveness, reversibility, or acceptability. Despite growing demand
GynecologySharing the contraceptive burden: men step into the game
By Lila Rouland | Published September 25, 2025 | 2 min read#Contraception #MaleContraception #Gynecology #Testosterone For more than half a century, contraception has rested primarily on women’s shoulders. But a turning point seems to be approaching: research on hormonal male contraception is progressing rapidly, opening the way to a new era of shared responsibility. The strategy relies on a simpl
GynecologyHormonal contraception: what women really say online
By Ana Espino | Published on september 25, 2025 | 3 min read#HormonalContraception Hormonal contraception is widely used around the world to prevent unwanted pregnancies. It is also at the center of a growing debate about its side effects. While clinical trials provide a quantitative assessment of risks, they often overlook women’s lived daily experiences. Yet, these experiences play a crucial rol
GynecologyThe pill, myths & realities: what you’re not (often) told
By Ana Espino | Published on september 24, 2025 | 3 min read#HormonalContraception #ReproductiveHealth #HealthMisinformation #Hormones Long heralded as a major advance for women’s reproductive autonomy, hormonal contraception is increasingly questioned today—despite its well-established benefits. This skepticism is rooted in a specific climate of misinformation. Side effects, often poorly explaine